Intelligent hydrogels for targeted cancer theranostics: Smart solutions to a complex disease

Authors: Mirmasoudi, Seyyedeh Sahra; Tomita, Kazuo; Kuwahara, Yoshikazu; Sato, Tomoaki; Roudkenar, Mehryar Habibi

Source journal: Medical oncology (Northwood, London, England) (2026-11-19)

DOI: 10.1007/s12032-026-03515-z

Abstract

Intelligent hydrogels constitute revolutionary tools in oncology and cancer treatment, opening up unprecedented avenues spanning targeted drug delivery, combination therapy, biosensing, and diagnostic imaging. Methodically, integrating nanomaterials, such as quantum dots, gold nanoparticles, carbon nanotubes, and magnetic nanoparticles renders smart hydrogels responsive to tumor-specific stimuli, including pH, redox gradients, enzymatic activity, and external fields. This stimulus-responsive behavior facilitates site-specific and on-demand release of therapeutic agents, consequently enhancing therapeutic efficacy, reducing systemic toxicity, and overcoming limitations of conventional chemotherapy approaches. Furthermore, these hydrogels, with their multifunctionality, can be used for combination therapies to co-deliver chemotherapeutics, immunotherapies, and gene therapies. This can be achieved by simultaneous real-time monitoring through integrated imaging probes, advancing the theranostic paradigm. In the context of precision medicine, hydrogel-based biosensors appear promising for detecting cancer biomarkers, such as exosomal RNA, proteins, and genetic mutations, with high sensitivity and in a non-invasive fashion. As for diagnostic imaging, hydrogel formulations harboring contrast agents pave the way for longitudinal tracking of therapeutic outcomes by significantly improving tumor visualization across various imaging modalities, including MRI, CT, ultrasound, and fluorescence. In the face of current challenges in terms of immunogenicity, scalability, and regulatory translation from bench to bedside, the rapidly evolving intelligent hydrogels hold promise in preclinical models for next-generation cancer management, offering potential pathways toward personalized and adaptive oncology.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.